235 related articles for article (PubMed ID: 28293192)
1. Indole Alkaloids from Plants as Potential Leads for Antidepressant Drugs: A Mini Review.
Hamid HA; Ramli AN; Yusoff MM
Front Pharmacol; 2017; 8():96. PubMed ID: 28293192
[TBL] [Abstract][Full Text] [Related]
2. Potential for interaction of kava and St. John's wort with drugs.
Singh YN
J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
[TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Prospects of Naturally Occurring and Synthetic Indole Alkaloids for Depression and Anxiety Disorders.
Munir S; Shahid A; Aslam B; Ashfaq UA; Akash MSH; Ali MA; Almatroudi A; Allemailem KS; Rajoka MSR; Khurshid M
Evid Based Complement Alternat Med; 2020; 2020():8836983. PubMed ID: 33123212
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models.
Fiebich BL; Knörle R; Appel K; Kammler T; Weiss G
Fitoterapia; 2011 Apr; 82(3):474-80. PubMed ID: 21185920
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
6. Anti-anxiety Properties of Selected Medicinal Plants.
Khan A; Akram M; Thiruvengadam M; Daniyal M; Zakki SA; Munir N; Zainab R; Heydari M; Mosavat SH; Rebezov M; Shariati MA
Curr Pharm Biotechnol; 2022; 23(8):1041-1060. PubMed ID: 33480339
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
8. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
9. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Sarris J; Kavanagh DJ
J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
[TBL] [Abstract][Full Text] [Related]
10. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
11. St John's wort for depression.
Linde K; Mulrow CD
Cochrane Database Syst Rev; 2000; (2):CD000448. PubMed ID: 10796719
[TBL] [Abstract][Full Text] [Related]
12. St John's Wort (Hypericum perforatum)--a herbal antidepressant.
Hippius H
Curr Med Res Opin; 1998; 14(3):171-84. PubMed ID: 9787983
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
14. The importance of pharmacological synergy in psychoactive herbal medicines.
Spinella M
Altern Med Rev; 2002 Apr; 7(2):130-7. PubMed ID: 11991792
[TBL] [Abstract][Full Text] [Related]
15. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse.
Soulimani R; Younos C; Jarmouni S; Bousta D; Misslin R; Mortier F
J Ethnopharmacol; 1997 Jun; 57(1):11-20. PubMed ID: 9234160
[TBL] [Abstract][Full Text] [Related]
16. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
17. St John's wort for depression.
Linde K; Mulrow CD; Berner M; Egger M
Cochrane Database Syst Rev; 2005 Apr; (2):CD000448. PubMed ID: 15846605
[TBL] [Abstract][Full Text] [Related]
18. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
Bukhari IA; Dar A
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of alkaloids and flavonoids from aerial parts of Passiflora species and dietary supplements using UPLC-UV-MS and HPTLC.
Avula B; Wang YH; Rumalla CS; Smillie TJ; Khan IA
Nat Prod Commun; 2012 Sep; 7(9):1177-80. PubMed ID: 23074901
[TBL] [Abstract][Full Text] [Related]
20. Phytotherapy of mood disorders in the light of microbiota-gut-brain axis.
Korczak M; Pilecki M; Granica S; Gorczynska A; Pawłowska KA; Piwowarski JP
Phytomedicine; 2023 Mar; 111():154642. PubMed ID: 36641978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
